News & AnalysisValo Health grabs $190m Series BBoston-based Valo Health LLC, a drug development platform, has raised $190 million in Series B financing.ByIris Dorbian2 July 2021•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs